Apyx Medical Corporation · NASDAQ:APYX
Waldman Lawrence exercised options for 12,000 Apyx Medical Corporation shares (Form 4)
Traded Jun 30, 2026 · Filed Jul 2, 2026
On Jun 30, 2026, Waldman Lawrence (Director) exercised options for 12,000 Apyx Medical Corporation shares at US$1.88 for US$22,560, leaving 12,314 shares. Filed Jul 2, 2026 (Form 4).
- Options exercised
- 12,000 shares
- Price
- US$1.88
- Value
- US$22,560
- Holding after
- 12,314 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock | Option exercise | 12,000 | US$1.88 | 17,338 | Indirect |
| Jun 30, 2026 | Common Stock | Shares withheld for tax | 5,024 | US$4.49 | 12,314 | Indirect |
Source
Related
- Apyx Medical Corporation
- Waldman Lawrence
- Apyx Medical Corporation shareholders
- Schedule 13G/A · Royce & Associates LP · Jul 21, 2026
- Form 4 · Roman Shawn David · Jun 17, 2026
- Form 4 · Vizirgianakis Stavros G. · Jun 15, 2026
- Schedule 13G/A · Nantahala Capital Management, LLC · Feb 13, 2026
- Schedule 13G/A · Royce & Associates LP · Jan 20, 2026